NCT00318422已完成3 期
Liraglutide Effect and Action in Diabetes (LEAD-1): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Glimepiride Versus Glimepiride Monotherapy Versus Glimepiride and Rosiglitazone Combination Therapy in Subjects With Type 2 Diabetes.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 1,041
- 试验地点
- 128
- 主要终点
- HbA1c
研究概览
简要总结
This trial is conducted globally (the United States of America excepted). This trial is designed to show the effect of treatment with liraglutide when added to existing glimepiride therapy and to compare this to both glimepiride monotherapy and to rosiglitazone as add-on therapy to glimepiride.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes
- •Treatment with oral anti-diabetic drugs for at least 3 months
- •HbA1c: 7.0-11.0 % (both incl.) in subjects on OAD monotherapy. 7.0-10.0 % (both incl.) in subjects on OAD combination therapy
- •Body Mass Index (BMI) less than or equal to 45.0 kg/m2.
排除标准
- •Treatment with insulin within the last three months
- •Treatment with any drug that could interfere with the glucose level
- •Any serious medical condition
- •Females who are pregnant, have the intention of becoming pregnant or are breastfeeding
结局指标
主要结局
HbA1c
时间窗: after 26 weeks of treatment
次要结局
- body weight
- Safety and tolerability
- beta-cell function
- Glycemic control parameters (fasting plasma glucose, -glucose profiles)
研究者
研究点 (128)
Loading locations...
相似试验
已完成
3 期
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherDiabetesDiabetes Mellitus, Type 2NCT00318461Novo Nordisk A/S1,091
终止
3 期
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cDiabetesDiabetes Mellitus, Type 2NCT00294723Novo Nordisk A/S746
已完成
3 期
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2DiabetesNCT00331851Novo Nordisk A/S584
已完成
3 期
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin TherapyDiabetesDiabetes Mellitus, Type 2NCT01618162Novo Nordisk A/S435
已完成
3 期
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyDiabetesDiabetes Mellitus, Type 2NCT01676116Novo Nordisk A/S438